Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H40O5 |
| Molecular Weight | 408.5714 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1(CCC1)[C@H](O)C\C=C\[C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)OC
InChI
InChIKey=XRISENIKJUKIHD-LHQZMKCDSA-N
InChI=1S/C24H40O5/c1-3-14-24(15-9-16-24)22(27)12-8-11-19-18(20(25)17-21(19)26)10-6-4-5-7-13-23(28)29-2/h8,11,18-19,21-22,26-27H,3-7,9-10,12-17H2,1-2H3/b11-8+/t18-,19-,21-,22-/m1/s1
| Molecular Formula | C24H40O5 |
| Molecular Weight | 408.5714 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Butaprost, a structural analog of PGE2, is a selective agonist for the EP2 receptor subtype. EP2 receptors are expressed on human neutrophils and on respiratory, vascular, and uterine smooth muscle. Butaprost binds with about 1/10 the affinity of PGE2 to the recombinant murine EP2 receptor and does not bind appreciably to the other murine EP receptors or the DP, TP, FP, and IP receptors. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and animal tissues and cells. Butaprost effectively reduces the subconjunctival scarring response. Given the significance of wound healing modulation in blebs, butaprost's inhibitory effect on subconjunctival Tenon's fibroblasts may be beneficial in managing postoperative scarring in glaucoma surgery.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| EP2 Receptor Signaling Regulates Microglia Death. | 2015-07 |
|
| Role of hypoxia-inducible factor 1, α subunit and cAMP-response element binding protein 1 in synergistic release of interleukin 8 by prostaglandin E2 and nickel in lung fibroblasts. | 2013-07 |
|
| The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. | 2011-06 |
|
| Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. | 2009-03-16 |
|
| Trigeminal nociceptors express prostaglandin receptors. | 2008-03 |
|
| PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11beta-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells. | 2007-09 |
|
| Exploration of prostanoid receptor subtype regulating estradiol and prostaglandin E2 induction of spinophilin in developing preoptic area neurons. | 2007-05-25 |
|
| Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. | 2005-11-18 |
|
| Spinal EP receptors mediating prostaglandin E2-induced mechanical hyperalgesia, thermal hyperalgesia, and touch-evoked allodynia in rats. | 2003-09 |
|
| Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes. | 2001-10-12 |
|
| Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. | 2000-11-30 |
|
| Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. | 1997-09 |
|
| Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice. | 1995-04-17 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:08 GMT 2025
by
admin
on
Mon Mar 31 18:25:08 GMT 2025
|
| Record UNII |
HP16WVP23Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID8048993
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
5927
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
69648-38-0
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
C74369
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
5311035
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL271896
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
X-64
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
HP16WVP23Y
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
100000088480
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY | |||
|
SUB06008MIG
Created by
admin on Mon Mar 31 18:25:08 GMT 2025 , Edited by admin on Mon Mar 31 18:25:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |